Skip to content
Home/Companies/MedTech/Amber Therapeutics
Amber Therapeutics

Amber Therapeutics

MedTech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Amber Therapeutics?

Amber Therapeutics is currently owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage), since 2021.

Hand-verified · updated 2026-07-16

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorMedTech
StatusActive
Websitewww.amber-tx.com

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

YASA
YASA
Exited 2021
to
Allos
Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Stateful Robotics
Active
Deep TechUK· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Amber Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Amber Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Amber Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue